the present invention relates to novel compounds of formula , and their pharmaceutically acceptable salts and compositions containing them . the present invention also relates to a process for the preparation of above said novel compounds , and their pharmaceutically acceptable salts . the compounds of formula are useful in the treatment of various disorders that are related to 5 - ht 4 receptors .